Measles Virus Vaccination and Infection
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 30 June 2026 | Viewed by 18
Special Issue Editors
Interests: human viruses; molecular biology methods; public health
Special Issue Information
Dear Colleagues,
Measles is an acute viral disease, one of the most contagious and widespread; its symptoms include fever of up to 40 °C (105 °F), malaise, cough, coryza, conjunctivitis, and a typical maculopapular rash, which usually appears two to three days after the initial exposure to the virus. While, in general, the virus causes mild to moderately severe sickness, it can occasionally lead to complications such as pneumonia, encephalitis, and death. Also, post-infectious encephalitis may affect about one out of every 1,000 measles cases. The only way to prevent measles infection is through vaccination, with the first effective vaccine introduced in 1963 and the trivalent measles–mumps–rubella vaccine introduced in 1971. In 1974, measles was one of the first diseases targeted by the W.H.O., with extended immunization programs introduced worldwide. Despite all our efforts and a significant drop of measles cases, in the last decade, numerous outbreaks and epidemics were recorded globally, with confirmed measles cases rising from 132,940 in 2016 to 873,373 in 2019. During the COVID-19 pandemic, due to mitigation measures implemented, measles cases declined to 123,152 in 2021 only to rise again to 334,717 in 2024. From the beginning of 2025 to mid-February, measles cases had already reached 3,098, and this trend is expected to continue if measures are not taken to prevent further spread.
Our aim in launching this Special Issue is to investigate measles outbreaks and epidemics across all world regions, by presenting laboratory results, introducing novel methods and techniques for the confirmation and further analysis of measles strains, and by addressing immunization and vaccination aspects, with the ultimate goal of protecting public health.
Dr. Elina Horefti
Dr. Julia Dina
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- measles
- genotyping
- phylogenetic analysis
- vaccines
- vaccination status
- measles elimination
- public health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
